 Zynerba Pharmaceuticals Inc NASDAQ:ZYNE unveiled a poster highlighting sleep data from a study of its Zygel transdermal cannabinoid therapy at the Associated Professional Sleep Societies, SLEEP 2021 Annual meeting. This years SLEEP meeting is being held virtually and runs from June 10 through June 13. 